Form 4: Eastman Chemical Exec's RSU Vesting & Tax Withholding

Eastman Chemical's SVP & Chief Manufacturing Officer, Michelle H. Caveness, reported the vesting of restricted stock units and subsequent tax withholding.

Summary

• Michelle H. Caveness, SVP & Chf. Mfg. Ofc. at Eastman Chemical Co. (EMN), reported changes in her beneficial ownership.
• On October 1, 2025, 6,715 restricted stock units (RSUs) vested, fulfilling a three-year vesting period.
• Concurrently, 1,636 shares of common stock were withheld to satisfy tax liabilities associated with the RSU vesting.
• The shares withheld for tax purposes were valued at $61.96 per share.
• Following these transactions, Caveness directly beneficially owns 6,246 shares of Eastman Chemical Co. common stock.

Sentiment

Score: 7

Explanation: The filing reports a routine executive compensation event (RSU vesting and tax withholding), which is generally a neutral to slightly positive indicator as it reflects the payout of long-term incentives.

Positives

• The vesting of 6,715 restricted stock units demonstrates the payout of a long-term incentive plan, aligning executive interests with shareholder value creation.

Negatives

• No explicit negative aspects were identified in this routine insider transaction filing.

Risks

• No specific risks were identified in this routine insider transaction filing.

Future Outlook

Not applicable as this is a historical transaction report and does not contain forward-looking statements or guidance.

Industry Context

This is a routine insider transaction filing and does not provide specific information for broader industry trend analysis.

Stakeholder Impact

• Shareholders: Indicates executive's continued alignment with company performance through equity ownership.
• Employees: Reflects standard executive compensation practices.

Key Dates

Recommendation

This Form 4 filing details a routine vesting of restricted stock units and subsequent tax withholding for an executive. It does not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily reflects a standard component of executive compensation.

Keywords

EMN, Eastman Chemical, Michelle Caveness, Form 4, insider transaction, RSU, restricted stock units, stock vesting, executive compensation